CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference

Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI response Durable Clinical Observations and Favorable Safety Profile Observed in Heavily ...
Fred Hutch

CCR5 plays multiple roles in mucosal immunity

Immune cells expressing the receptor CCR5 are recruited to areas of inflammation by chemokine ligands, making CCR5 an attractive therapeutic target for preventing cell trafficking during conditions ...
Nature

CCR5-Δ32 mutation is strongly associated with primary sclerosing cholangitis

A 32-bp deletion in this gene (CCR5-Δ32 mutation) results in a nonfunctioning receptor that is trapped in the endoplasmic reticulum and therefore not expressed at the cell surface. 19, 20 The mutation ...

Creatv Bio's LifeTracDx® Blood Test Utilized as Exploratory Biomarker in CytoDyn's Phase 2 Study in Patients with Relapsed/Refractory Metastatic Colorectal Cancer

Creatv Bio, a Division of Creatv MicroTech, Inc. ("Creatv") has announced the initiation of a collaboration with CytoDyn Inc. of Vancouver, Washington ("CytoDyn") to provide its' LifeTracDx® liquid ...
Nature

Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5

CCR5 is one of the primary coreceptors for Env-mediated fusion between cells and human immunodeficiency virus type 1 (HIV-1). Analyses of CCR5 variants in cohorts of HIV-1 high-risk individuals led to ...
Aidsmap

New CCR5 antagonist TBR-652 shows good antiviral activity in early study

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Aidsmap

Merck stops development of CCR5 inhibitor vicriviroc

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
The New England Journal of Medicine

Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation

Here, we present the case of a 27-year-old patient with HIV-1 infection and anaplastic large-cell lymphoma. Because of a poor prognosis after progression of the T-cell lymphoma, stem-cell ...
FierceBiotech

Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS

RICHMOND, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that its collaborators at the University of Pennsylvania ...
PharmiWeb

CCR5 Antagonists Market in HIV & Rare Inflammatory Conditions to Reach $300 Million by 2025, Driven by Expanding Clinical Pipeline and Indication Diversification

CCR5 Antagonists Market in HIV & Rare Inflammatory Conditions to Reach $300 Million by 2025, Driven by Expanding Clinical Pipeline and Indication Diversification The global CCR5 antagonists market ...
bangaloremirror.indiatimes

A protein called CCR5

Two pieces of news have gripped the medical science community over the last few weeks. The first is that of the scientist He Jiankui producing genetically engineered twins that were resistant to HIV ...